Joint workshop on tools and systems used for prescription control (D2.07) & the ethical and legal aspects of adaptive decision making (D3.09)
On the 17th of January 2017, as part of its Annual Meeting, the ADAPT SMART consortium hosted a multi-stakeholder workshop on ‘Tools and systems used for prescription control and the ethical and legal aspects of adaptive decision making’. The topic of this workshop related to two different deliverables: D2.07 (focused on prescription control) and D3.09 (focused on ethical and legal aspects of adaptive decision making)
The objectives of the workshop were:
- To share an understanding of the in-depth analysis of the identified tools/systems to guide appropriate use, experience to date, and their feasibility and impact.
- To share an understanding of the ethical and legal aspects of prescription control under MAPPs between all major stakeholders, with a special focus on patients and health care professionals.
- To jointly explore potential recommendations to address the legal concerns, ethical concerns, how the current tools/systems can be sympathetic to and supportive of the MAPPs pathway, and any impact those solutions may have.
More than 30 representatives including; European regulators, Health Technology Assessment (HTA) bodies, the pharmaceutical industry, patient organizations, health care professionals and academics attended the workshop.
More information on adaptive pathways can be found at the European Medicines Agency (EMA) website. For more information about the Innovative Medicines Initiative (IMI) ADAPT-SMART project please click the link here.